佐剂
多糖
疫苗佐剂
免疫系统
地黄
传统医学
生物
医学
免疫学
中医药
生物化学
病理
替代医学
作者
Xinhuan Wan,Yiming Yin,Changzheng Zhou,Lin Hou,Qinghua Cui,Xiaoping Zhang,Xiaoqing Cai,Yuliang Wang,Lizhu Wang,Tian Jing-zhen
标识
DOI:10.1016/j.carbpol.2021.118739
摘要
Adjuvants have been used in vaccines for a long time to promote the body's immune response, reducing vaccine dosage and production costs. Although many vaccine adjuvants are developed, the use in human vaccines is limited because of either limited action or side effects. Therefore, the development of new vaccine adjuvants is required. Many studies have found that natural polysaccharides derived from Traditional Chinese medicine (TCM) possess good immune promoting effects and simultaneously improve humoral, cellular and mucosal immunity. Recently polysaccharide adjuvants have attracted much attention in vaccine preparation because of their intrinsic characteristics: immunomodulation, biocompatibility, biodegradability, low toxicity and safety. This review article systematically analysed the literature on polysaccharides possessing vaccine adjuvant activity from TCM plants, such as Astragalus polysaccharide (APS), Rehmannia glutinosa polysaccharide (RGP), Isatis indigotica root polysaccharides (IRPS), etc. and their derivatives. We believe that polysaccharide adjuvants can be used to prepare the vaccines for clinical use provided their mechanisms of action are studied in detail.
科研通智能强力驱动
Strongly Powered by AbleSci AI